Using UNC's expertise to fight emerging diseases
Fri Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that.
Share: Facebook | Twitter | Email
Related: Campus Connections
Recent Campus Connections News:How Carolina is transforming medicine with artificial intelligenceWednesday September 19, 2018For 30 years, Stone Center has been bringing people togetherWednesday September 19, 2018Great college football (and foodie) towns to visit this fallTuesday September 18, 2018Hurricane Florence: How to support the recovery effortsSunday September 16, 2018UNC-Chapel Hill to host shelter to serve people displaced by Hurricane FlorenceSaturday September 15, 2018